CRDF Cardiff Oncology, Inc.
Nasdaq · SEC CIK 1213037 · EDGAR
- Bought, last 12 months
- $1.12M 4 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 75 since 2021-07-12, latest 2026-07-16 16:03
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| PACE GARY W | Dir | $1.04M | — |
| Mohindru Mani | CEO, Dir | $79.9K | — |
Transactions 21
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-16 16:03 | 2026-07-14 | CRDF | PACE GARY W | Dir | P - Purchase | $1.46 | +687.3K | 2.04M | +51% | +$1000.0K |
| D | 2026-07-16 16:01 | 2026-07-14 | CRDF | Mohindru Mani | CEO, Dir | P - Purchase | $1.46 | +34.4K | 59.1K | +139% | +$50.0K |
| 2026-06-22 09:00 | 2026-06-18 | CRDF | Mohindru Mani | CEO, Dir | P - Purchase | $1.21 | +24.7K | 24.7K | New | +$29.9K | |
| 2026-06-22 09:00 | 2026-06-18 | CRDF | PACE GARY W | Dir | P - Purchase | $1.22 | +30.0K | 1.36M | +2% | +$36.6K | |
| 2025-07-31 | 2025-07-30 | CRDF | PACE GARY W | Dir | P - Purchase | $2.45 | +275.0K | 1.33M | +26% | +$673.8K | |
| I | 2025-07-31 | 2025-07-30 | CRDF | PACE GARY W | Dir | P - Purchase | $2.45 | +15.0K | 1.35M | +1% | +$36.8K |
| MI | 2024-12-18 | 2024-12-16+ | CRDF | Levine James E. | CFO | P - Purchase | $4.76 | +7,716 | 67.7K | +13% | +$36.7K |
| 2024-12-16 | 2024-12-12 | CRDF | TANNENBAUM RENEE P | Dir | P - Purchase | $3.42 | +10.0K | 20.0K | +100% | +$34.2K | |
| I | 2024-12-12 | 2024-12-11 | CRDF | PACE GARY W | Dir | P - Purchase | $2.60 | +11.5K | 1.06M | +1% | +$29.9K |
| 2024-12-12 | 2024-12-11 | CRDF | PACE GARY W | Dir | P - Purchase | $2.60 | +350.1K | 1.05M | +50% | +$910.3K | |
| 2023-12-19 | 2023-12-19 | CRDF | PACE GARY W | Dir | P - Purchase | $1.37 | +30.0K | 697.8K | +4% | +$41.1K | |
| 2023-11-14 | 2023-11-10 | CRDF | PACE GARY W | Dir | P - Purchase | $0.98 | +22.9K | 667.8K | +4% | +$22.5K | |
| 2022-11-29 | 2022-11-25 | CRDF | Erlander Mark | CEO, Dir | P - Purchase | $1.43 | +10.0K | 24.5K | +69% | +$14.3K | |
| I | 2022-10-11 | 2022-09-16 | CRDF | Armitage James O | Dir | P - Purchase | $1.56 | +13.0K | 13.0K | New | +$20.3K |
| I | 2022-09-20 | 2022-09-19 | CRDF | White Lale | Dir | P - Purchase | $1.64 | +15.0K | 113.8K | +15% | +$24.6K |
| 2022-09-19 | 2022-09-15 | CRDF | PACE GARY W | Dir | P - Purchase | $1.71 | +150.0K | 644.8K | +30% | +$256.5K | |
| 2022-09-19 | 2022-09-16 | CRDF | Levine James E. | CFO | P - Purchase | $1.56 | +30.0K | 60.0K | +100% | +$46.8K | |
| M | 2022-09-19 | 2022-09-15 | CRDF | TANNENBAUM RENEE P | Dir | P - Purchase | $1.72 | +10.0K | 10.0K | New | +$17.2K |
| DI | 2022-07-06 | 2022-07-05 | CRDF | White Lale | Dir | M - OptEx | $2.60 | +28.9K | 98.8K | +41% | +$75.0K |
| 2021-09-22 | 2021-09-21 | CRDF | PACE GARY W | Dir | P - Purchase | $6.75 | +30.0K | 494.8K | +6% | +$202.5K | |
| M | 2021-09-13 | 2021-09-10 | CRDF | Levine James E. | CFO | P - Purchase | $6.47 | +30.0K | 30.0K | New | +$194.0K |
Purchase Sale Sale after option exercise All abbreviations